The Risk Factors and Optimal Prevention Strategies of VTE in Sickle Cell Disease – RPTH Journal
RPTH Journal shared on LinkedIn about a recent article by Neha Bhasin et al, adding:
”Risk factors for venous thromboembolism in sickle cell disease
Sickle cell disease (SCD) is well known to increase the risk of venous thromboembolism (VTE),but who is most at risk, and how often does VTE recur?
A new retrospective study in RPTH examined 719 individuals with SCD over a 10-year period to answer these questions.
Key findings from 64 patients who developed VTE:
- 8.9% of the cohort developed at least one VTE
- VTE recurrence rate: 31%
Major risk factors:
- History of VTE
- History of stroke
- ≥6 hospitalisations in 12 months
Additional risk factors: hormonal therapy, smoking , and central venous catheter use
Prospective studies are needed to validate these risk factors and evaluate optimal prevention strategies.”
Title: Risk factors for venous thromboembolism in sickle cell disease
Authors: Neha Bhasin, Li Zhang, Ayotola Ajayi, Seva Patel, Taylor Imai, Shreya Agarwal
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 21, 2026, 01:57A New Approach to Understanding Plasmin Generation and Fibrinolysis – RPTH Journal
-
Jul 21, 2026, 01:52Maria Diaz Alonso: Delivering My First International Oral Presentation at ISTH 2026
-
Jul 21, 2026, 01:44Megan Preece: Presenting New Research on Antiphospholipid Syndrome at ISTH 2026
-
Jul 21, 2026, 01:28Dhamirah Nazihah Mohd Nasiruddin: A Milestone in My Haemostasis and Thrombosis Journey at ISTH 2026
-
Jul 21, 2026, 00:55Anita Brikman on PPTA’s First-Half 2026 Achievements
-
Jul 21, 2026, 00:50Caitlin Raymond: Can Therapeutic Plasma Exchange Reduce Microplastics?
-
Jul 21, 2026, 00:46Yohei Hisada: Science, Collaboration, and New Beginnings at ISTH 2026
-
Jul 21, 2026, 00:41Ahmed Koriesh: Inside Our 2026 Stroke Simulation Lab
-
Jul 20, 2026, 21:17Connie Montgomery: Building Community Through the HFA Black Voices Summit